Cipla on Maharashtra FDA action: ‘Disappointing’, says Pune warehouse follows
Maharashtra FDA cancels Cipla’s Pune warehouse licences over Reactin Plus packaging and storage violations. Cipla responds.
Source
<meta name="google-adsense-account" content="ca-pub-6363428395369086">
- Gold, silver prices: What is driving volatility in bullion markets
- SEBI’s REIT, InvIT overhaul: What investors can expect